Premium
Skipping of exon 12 as a consequence of a point mutation (1898 + 5G → T) in the cystic fibrosis transmembrane conductance regulator gene found in a consanguineous Chinese family
Author(s) -
Zielenski Julian,
Markiewicz Danuta,
Lin ShuanPei,
Huang FuYuan,
YangFeng Teresa L.,
Tsui LapChee
Publication year - 1995
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/j.1399-0004.1995.tb03944.x
Subject(s) - exon , genetics , point mutation , biology , allele , intron , cystic fibrosis transmembrane conductance regulator , gene , microbiology and biotechnology , exon skipping , mutation , coding region , rna splicing , splice site mutation , mutant , alternative splicing , rna
A point mutation (1898+5G→T) located five base pairs downstream from the donor splice site in intron 12 of the CFTR gene has been identified in a consanguineous CF patient of Chinese origin. To determine if this nucleotide substitution could affect mRNA splicing, PCR analysis was performed with RNA isolated from the lymphoblastoid cell line of the mother of the deceased patient. While exon 12‐minus transcript was detected in this sample, it was also found in individuals without 1898+5G→T, albeit in a smaller proportion. Using a sequence polymorphism associated with each of the two alleles in the mother, however, we showed that mutant transcript was almost exclusively produced by the 1898+5G→T allele. Skipping of exon 12 would result in the deletion of 29 amino acids from the first nucleotide binding domain of CFTR, rendering the protein non‐functional. The possibility of a low level (2.5%) of normal transcript from the mutant allele cannot be excluded and it may explain the pancreatic sufficient phenotype of the patient. The 1898+5G→T mutation was found in two other CF patients of Chinese origin, but it was not detected in 192 CF chromosomes of Caucasian origin and 30 other chromosomes from Chinese individuals without a family history of CF.